Web Seminar: The Role of PharmEcovigilance in Reducing the Environmental Footprint of Pharmaceuticals
Ilene S Ruhoy, MD, PhD, Assistant Professor, Touro University and US EPA Environmental Sciences Division
Tuesday, April 14, 2009 12:00 PM - 1:00 PM EDT
The prescribing and usage of medications have ramifications extending far beyond conventional medical care. The pharmaceutical and healthcare industries have an environmental footprint because the active pharmaceutical ingredients (APIs) can enter the environment as contaminants by a variety of routes, primarily from excretion, bathing, and disposal. Disposal of unwanted, leftover medications by flushing into sewers has been considered a secondary route - - one that supposedly does not contribute substantially to overall environmental loadings of APIs. This presentation is an examination of secondary routes of API release to the environment and for direct but unintentional human exposure. These routes include: (a) bathing, washing, and laundering, and (b) disposal of unused and partially used high-content medical devices. Understanding these secondary routes is important from the perspective of pollution prevention, as well as for reducing the incidence of unintentional and purposeful poisonings of humans and pets, and for improving the quality and cost-effectiveness of healthcare.
Sign up here:
https://www1.gotomeeting.com/register/909165450
Use priority code:G1M1481W1Blog/LI
Tuesday, April 14, 2009 12:00 PM - 1:00 PM EDT
The prescribing and usage of medications have ramifications extending far beyond conventional medical care. The pharmaceutical and healthcare industries have an environmental footprint because the active pharmaceutical ingredients (APIs) can enter the environment as contaminants by a variety of routes, primarily from excretion, bathing, and disposal. Disposal of unwanted, leftover medications by flushing into sewers has been considered a secondary route - - one that supposedly does not contribute substantially to overall environmental loadings of APIs. This presentation is an examination of secondary routes of API release to the environment and for direct but unintentional human exposure. These routes include: (a) bathing, washing, and laundering, and (b) disposal of unused and partially used high-content medical devices. Understanding these secondary routes is important from the perspective of pollution prevention, as well as for reducing the incidence of unintentional and purposeful poisonings of humans and pets, and for improving the quality and cost-effectiveness of healthcare.
Sign up here:
https://www1.gotomeeting.com/register/909165450
Use priority code:G1M1481W1Blog/LI
|
Share this article with your social network, just click below to share now!
|
|
|
1 comment :
Do you know of other resources that discuss the footprint of the pharma sector?
Post a Comment